Value Investor
Start free

Cellebrite DI

CLBT on Nasdaq. Prepackaged software. Market value $2.8bn.

Watch this stockFree. We tell you when something changes.

This company reports once a year (it is based outside the US), so every figure comes from its annual report for the year to December 2025.

We can't read total debt from the filing, so debt is left out.

Should I look at this?

Worth a closer look

Why it could be worth it

What to watch out for

Nothing stood out in the numbers we check.

Read what could go wrong

This is not advice. Check the numbers below.

Compare with another stock

Cash yield
annual report to December 2025
5.7%fair

For every $100 of what the whole company costs, it produced $5.65 of spare cash last year. A savings account pays about $4.

Price to profit
annual report to December 2025
n/a

The filings do not give us enough to work this out.

Return on capital
five annual reports to December 2025
n/a

The filings do not give us enough to work this out.

Quality score: 73 of 100. Price score: 63 of 100. Our list needs 70 on quality and 60 on price.

$11.37 a share, 19% above its 1-year low

Over the past year the price has ranged from $9.58 to $19.98.

Pays no dividend

Prices from Tuesday’s close (6 October).

Five years of cash, in billions

0.0
0.0
0.1
0.1
0.2
20212022202320242025
Revenue
$246m$271m$325m$401m$476m
Operating margin
5.6%0.4%10.2%14.2%14.0%
Debt to equity
n/an/an/an/an/a
Shares outstanding
0.19bn0.19bn0.21bn0.24bn0.25bn

Health checks

  • Free cash flow positive5 of 5 years
  • Accounting looks honest (Beneish)Not enough data
  • Financial strength (Piotroski)4 of 8 checks we could run
  • Profit backed by cash (accruals)No
  • DebtUnknown
  • Revenue growth, five yearsStrong, 17.9% a year
  • Buying back its own sharesNo, 32% more shares since 2021

Dates

Next results (estimated)
n/a
Last annual report (10-K)
3 March 2026
Next quarterly (estimated, 10-Q)
n/a

Who owns it

5 long-term investors we follow own it, unchanged from 5 last quarter. 201 funds in all.

Jun '25
Dec '25
Jun '26

Sold out this quarter

Largest holders overall

From 13F filings for the quarter ended 30 June 2026.

Big holders and activists

4 investors own more than 5%.

  • SUNCORPORATION
    Passive investor
    42.7%−1.0 pts
    Since 31 December 2025
  • Adam H. Clammer
    at least 6.1%
    (filed with 6 related holders)
    Since 18 March 2025
  • Voss Capital
    Passive investor
    at least 5.1%
    (filed with 4 related holders)
    Since 13 August 2026
  • FMR LLC
    Passive investor
    at least 4.1%−1.1 pts
    (filed with 1 related holder)
    Since 31 March 2025
  • IGP Saferworld, Limited Partnership
    Passive investor
    Sold down below 5%
    Since 31 December 2024

From Schedule 13D and 13G filings: anyone owning more than 5% must file one.

What insiders did

No insider bought shares on the open market in the last 12 months. 4 sold $5m, $123,599 of it under preset trading plans.

  • GEE DAVID NICHOLAS
    Chief Marketing Officer
    Sold
    under a preset trading plan
    Date
    24 August 2026
    Shares
    4,323
    Price
    $11.36
    Value
    $49,111
  • Jewell Marcus
    Global Chief Revenue Officer
    Sold
    Date
    21 August 2026
    Shares
    12,562
    Price
    $11.24
    Value
    $141,217
  • GEE DAVID NICHOLAS
    Chief Marketing Officer
    Sold
    Date
    21 August 2026
    Shares
    2,198
    Price
    $11.24
    Value
    $24,709
  • Hogan Thomas E.
    Chief Executive Officer, Director
    Sold
    Date
    12 August 2026
    Shares
    139,713
    Price
    $15.39
    Value
    $2m
  • Jewell Marcus
    Global Chief Revenue Officer
    Sold
    Date
    12 August 2026
    Shares
    411
    Price
    $16.07
    Value
    $6,604
  • GEE DAVID NICHOLAS
    Chief Marketing Officer
    Sold
    Date
    12 August 2026
    Shares
    230
    Price
    $16.07
    Value
    $3,696
  • Barter David
    Chief Financial Officer
    Sold
    Date
    8 July 2026
    Shares
    41,734
    Price
    $16.38
    Value
    $683,419
  • Hogan Thomas E.
    Chief Executive Officer, Director
    Sold
    Date
    2 July 2026
    Shares
    103,188
    Price
    $15.76
    Value
    $2m
  • GEE DAVID NICHOLAS
    Chief Marketing Officer
    Sold
    under a preset trading plan
    Date
    21 May 2026
    Shares
    5,673
    Price
    $13.13
    Value
    $74,488
  • Jewell Marcus
    Global Chief Revenue Officer
    Sold
    Date
    18 May 2026
    Shares
    12,658
    Price
    $12.77
    Value
    $161,643

From Form 4 filings: insiders must report trades in their own company's shares within two days.

Warning signs in its filings

Problems the company itself reported to the SEC, in its own words.

Cellebrite DI doesn’t file a US annual report (10-K), so we haven’t checked it.

A 10-K is the yearly report every US company files with the SEC. An 8-K is a short notice of a big event.

What could go wrong

Cheap for a reason is the question the numbers cannot answer.

Whether the price already reflects the risks is what the deep dive is for.

The deep dive

Everything above is arithmetic on public filings. The deep dive reads the last ten years of annual reports, the proxy statements, and the earnings calls, then argues the case the way Buffett, Klarman, and Hohn would, and checks every claim against the source.

  • What the business is worth, as a range, and the margin of safety at today’s price
  • Prices to start buying, buy, and buy hard
  • The three things that would make this a mistake
  • Every number footnoted to the filing it came from
Create a free account to run it

Your first deep dive is free.

What a finished deep dive looks like

Not advice. Numbers on this page come from SEC filings and are updated each night; prices are updated again after the US market closes. The five-year figures are rounded.